Melinta Pharmaceuticals Inc is categorized under in New York City, NY .
Business Name: | Melinta Pharmaceuticals Inc |
Contact Person: | Kevin Ferro |
Address: | 499 Park Avenue Floor 6, New York City, New York 10022 |
Phone Number: | (646) 328-1333 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founding Year: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | |
SIC Code: | 2834 |
NAICS Code: | 325412 |
Share This Business: | |
Related Businesses: |
Lightlake Therapeutics Inc - New York City, NY 10022 Krele LLC - New York City, NY 10022 Aoi Pharma Inc - New York City, NY 10022 Niobe Ventures LLC - New York City, NY 10022 Ohr Pharmaceutical Inc - New York City, NY 10022 Stemline Therapeutics Inc - New York City, NY 10022 Bristol-Myers Squibb Company - New York City, NY 10022 Forest Laboratories Inc - New York City, NY 10022 Keryx Biopharmaceuticals Inc - New York City, NY 10022 Tonix Pharmaceuticals Inc - New York City, NY 10022 Danube Pharmaceuticals Inc - New York City, NY 10022 |
The company Melinta Pharmaceuticals Inc provides BOTH services in the form of from its single location in New York. 1 to 4 employees work for Melinta Pharmaceuticals Inc, and the business now earns $100.000 to $499.999 per annum.
Melinta Pharmaceuticals Inc was launched in 2009 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Melinta Pharmaceuticals Inc, please call Kevin Ferro with the phone number (646) 328-1333 or visit its single location at 499 Park Avenue Floor 6 in New York City, New York 10022.
The location of the single location can also be found using the coordinates 40.762683,-73.969622. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.